Abstract
AIM : To describe the presentation and outcome of rhino-orbital-cerebral mucormycosis (ROCM) in adolescents with type 1 diabetes mellitus (T1 DM).Methods : the medical records of six patients of T1 DM with ROCM admitted between October 2001 to January 2004 were analysed.Results : the mean (± SD) age and duration of DM of these patients were 16.1 ±3.0 years and 26.3 ± 24.9 months respectively. Four patients had ROCM at presentation, while two developed it during their hospital stay when recovering from diabetic ketoacidosis. Proptosis (100%) and ptosis (100%) were the most common symptoms, and ophthalmoplegia (85%) and vision loss (85%) were the most common signs. Maxillary sinus (85%) was the commonest paranasal sinus to be involved. All patients received amphotericin B and had appropriate surgery except one. Four patients survived. Patients who had altered sensorium, facial necrosis, palatal perforation and cerebral involvement at presentation had poor outcome.Conclusion : High index of suspicion of ROCM in T1 DM and combined approach with amphotericin B and appropriate surgery is rewarding.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis: Major Review.Surv Ophthalmol 1994; 39: 3–22.
Ferry AP, Abedi S. Diagnosis and management of rhinoorbital cerebral mucormycosis (phycomycosis): a report of 16 personally observed cases.Ophthalmology 1983; 90: 1096–1104.
Parfrey AN. Improved diagnosis and prognosis of mucormycosis: A clinicopathological study of 33 cases.Medicine 1986; 65: 113–123.
West BC, Oberle AD, Chung KJK. Mucormycosis caused by Rhizopus microsporus var. microsporus: cellulitis in the leg of a diabetic patient cured by amputation:J Clin Microbiol 1995; 33: 3341–3344.
Kline HW. Mucormycosis in children: review of the literature and report of cases.Pediatr Infect Dis 1985; 4: 672–676.
Artis WM, Fountain JA, Delcher HK. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability.Diabetes 1982; 31: 109–114.
Marchevskey AM, Bottone EJ, Geller SA. the changing spectrum of disease etiology and diagnosis of mucormycosis.Human Pathology 1980; 11: 457.
Moye J, Rosenbloom AL, Silverstein J. Cinical predictors of mucormycosis in children with type 1 diabetes mellitus.J Pediatr Endocrinol Metab 2002; 15: 1001–4.
Smith JL, Stevens DA. Survival in cerebro-rhino-orbital zygomycosis and cavernous sinus thrombosis with combined therapy.South Med J 1986; 79: 501–504.
Abramson E, Wilson D, Arky RA. Rhinocerebral phycomycosis in association with diabetic ketoacidosis.Ann Intern Med 1984; 1060–1062.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhadada, S., Bhansali, A., Reddy, K.S.S. et al. Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus. Indian J Pediatr 72, 671–674 (2005). https://doi.org/10.1007/BF02724075
Issue Date:
DOI: https://doi.org/10.1007/BF02724075